There are studies that must be performed in order to determine their clinical relevance. The process extends from bench top to bedside and incudes various special populations like pediatrics and geriatrics. This course addresses various elements related to the study of analgesics. Novel improved preclinical animal models in analgesic studies will be examined. The unique issues of unusually high placebo and nocebo effects in analgesic, which can lead to confusing results, will be discussed along with the role and responsibilities of acting as a principal investigator in an analgesic trial. This course will review the practical impact of new healthcare measures and the increased importance of comparative effectiveness trials, health and pharmacoeconomic outcomes, and the process of publishing data and determining authorship. At the conclusion of the program participants shall have a comprehensive understanding of analgesic trials. (Recorded at PAINWeek 2018)
Did you enjoy this article?
Subscribe to the PAINWeek Newsletter
and get our latest articles and more direct to your inbox